Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs

October 24, 2010- Gordon Guyatt, MD, epidemiologist, internist, and biostatistician at McMaster University updates us on the progress being made against the problem of clinical trials being stopped early to inflate efficacy of drugs. Since our first coverage of the topic two years ago, the FDA, the Cochrane group, and other agencies have implemented changes in policy.  Dr. Guyatt discusses the Crestor JUPITER trial as an example of a trial that was stopped early and inflated efficacy.

This entry was posted in Cardiology, FDA, McMaster University. Bookmark the permalink.

Leave a Reply